382 related articles for article (PubMed ID: 18217188)
1. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
[TBL] [Abstract][Full Text] [Related]
2. Temporal correlation of the memory deficit with Alzheimer-like lesions induced by activation of glycogen synthase kinase-3.
Wang Y; Zhang JX; Du XX; Zhao L; Tian Q; Zhu LQ; Wang SH; Wang JZ
J Neurochem; 2008 Sep; 106(6):2364-74. PubMed ID: 18643871
[TBL] [Abstract][Full Text] [Related]
3. Dendrobium nobile Lindl. alkaloid decreases Tau hyperphosphorylation via regulating PI3K/Akt/GSK-3β pathway in vitro and in vivo.
Huang J; Huang N; Qiu Y; Shi J
J Ethnopharmacol; 2024 Mar; 322():117592. PubMed ID: 38097026
[TBL] [Abstract][Full Text] [Related]
4. Prolonged Alzheimer-like tau hyperphosphorylation induced by simultaneous inhibition of phosphoinositol-3 kinase and protein kinase C in N2a cells.
Xu GG; Deng YQ; Liu SJ; Li HL; Wang JZ
Acta Biochim Biophys Sin (Shanghai); 2005 May; 37(5):349-54. PubMed ID: 15880264
[TBL] [Abstract][Full Text] [Related]
5. Activation of glycogen synthase kinase-3 induces Alzheimer-like tau hyperphosphorylation in rat hippocampus slices in culture.
Li X; Lu F; Tian Q; Yang Y; Wang Q; Wang JZ
J Neural Transm (Vienna); 2006 Jan; 113(1):93-102. PubMed ID: 15959856
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
[TBL] [Abstract][Full Text] [Related]
7. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory.
Liu SJ; Zhang AH; Li HL; Wang Q; Deng HM; Netzer WJ; Xu H; Wang JZ
J Neurochem; 2003 Dec; 87(6):1333-44. PubMed ID: 14713290
[TBL] [Abstract][Full Text] [Related]
8. Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells.
Greco SJ; Sarkar S; Casadesus G; Zhu X; Smith MA; Ashford JW; Johnston JM; Tezapsidis N
Neurosci Lett; 2009 May; 455(3):191-4. PubMed ID: 19429119
[TBL] [Abstract][Full Text] [Related]
9. Bip enhanced the association of GSK-3β with tau during ER stress both in vivo and in vitro.
Liu ZC; Fu ZQ; Song J; Zhang JY; Wei YP; Chu J; Han L; Qu N; Wang JZ; Tian Q
J Alzheimers Dis; 2012; 29(4):727-40. PubMed ID: 22460328
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease.
Sze CI; Su M; Pugazhenthi S; Jambal P; Hsu LJ; Heath J; Schultz L; Chang NS
J Biol Chem; 2004 Jul; 279(29):30498-506. PubMed ID: 15126504
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
[TBL] [Abstract][Full Text] [Related]
12. PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta.
Qian W; Shi J; Yin X; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F
J Alzheimers Dis; 2010; 19(4):1221-9. PubMed ID: 20308788
[TBL] [Abstract][Full Text] [Related]
13. Dehydroevodiamine attenuates tau hyperphosphorylation and spatial memory deficit induced by activation of glycogen synthase kinase-3 in rats.
Peng JH; Zhang CE; Wei W; Hong XP; Pan XP; Wang JZ
Neuropharmacology; 2007 Jun; 52(7):1521-7. PubMed ID: 17434540
[TBL] [Abstract][Full Text] [Related]
14. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
[TBL] [Abstract][Full Text] [Related]
15. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.
Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L
J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glycogen synthase kinase-3 reverses tau hyperphosphorylation induced by Pin1 down-regulation.
Xiong YS; Wang DL; Tan L; Wang X; Chen LM; Gong CX; Wang JZ; Zhu LQ
CNS Neurol Disord Drug Targets; 2013 May; 12(3):436-43. PubMed ID: 23469846
[TBL] [Abstract][Full Text] [Related]
17. Neuroglobin attenuates Alzheimer-like tau hyperphosphorylation by activating Akt signaling.
Chen LM; Xiong YS; Kong FL; Qu M; Wang Q; Chen XQ; Wang JZ; Zhu LQ
J Neurochem; 2012 Jan; 120(1):157-64. PubMed ID: 21496024
[TBL] [Abstract][Full Text] [Related]
18. Curcumin attenuates amyloid-β-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3β signaling pathway.
Huang HC; Tang D; Xu K; Jiang ZF
J Recept Signal Transduct Res; 2014 Feb; 34(1):26-37. PubMed ID: 24188406
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Wnt and PI3K signaling modulates GSK-3beta activity and induces morphological changes in cortical neurons: role of tau phosphorylation.
Mercado-Gómez O; Hernández-Fonseca K; Villavicencio-Queijeiro A; Massieu L; Chimal-Monroy J; Arias C
Neurochem Res; 2008 Aug; 33(8):1599-609. PubMed ID: 18461448
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of GSK-3β by calpain counteracts the inhibitory effect of Ser9 phosphorylation on GSK-3β activity induced by H₂O₂.
Feng Y; Xia Y; Yu G; Shu X; Ge H; Zeng K; Wang J; Wang X
J Neurochem; 2013 Jul; 126(2):234-42. PubMed ID: 23646926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
